Return On Equity in % of NovoCure Ltd from Q2 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NovoCure Ltd quarterly/annual Return On Equity history and change rate from Q2 2016 to Q3 2025.
  • NovoCure Ltd Return On Equity for the quarter ending 30 Sep 2025 was -50.3 %, a 21.2% decline year-over-year.
  • NovoCure Ltd annual Return On Equity for 2024 was -46.8 %, a 9.41% increase from 2023.
  • NovoCure Ltd annual Return On Equity for 2023 was -51.6 %, a 146% decline from 2022.
  • NovoCure Ltd annual Return On Equity for 2022 was -21 %, a 43.2% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

NovoCure Ltd Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -50.3 -8.81 -21.2% 01 Jul 2025 30 Sep 2025
Q2 2025 -47.7 -2.06 -4.51% 01 Apr 2025 30 Jun 2025
Q1 2025 -45.5 +4.89 +9.71% 01 Jan 2025 31 Mar 2025
Q4 2024 -46.8 +4.86 +9.41% 01 Oct 2024 31 Dec 2024
Q3 2024 -41.5 +5.41 +11.5% 01 Jul 2024 30 Sep 2024
Q2 2024 -45.7 -5.47 -13.6% 01 Apr 2024 30 Jun 2024
Q1 2024 -50.4 -18.3 -57.2% 01 Jan 2024 31 Mar 2024
Q4 2023 -51.6 -30.7 -146% 01 Oct 2023 31 Dec 2023
Q3 2023 -46.9 -28 -149% 01 Jul 2023 30 Sep 2023
Q2 2023 -40.2 -24.2 -151% 01 Apr 2023 30 Jun 2023
Q1 2023 -32 -17.8 -125% 01 Jan 2023 31 Mar 2023
Q4 2022 -21 -6.33 -43.2% 01 Oct 2022 31 Dec 2022
Q3 2022 -18.9 -12.4 -190% 01 Jul 2022 30 Sep 2022
Q2 2022 -16 -14.9 -1264% 01 Apr 2022 30 Jun 2022
Q1 2022 -14.2 -17.5 -531% 01 Jan 2022 31 Mar 2022
Q4 2021 -14.7 -20.8 -339% 01 Oct 2021 31 Dec 2021
Q3 2021 -6.5 -13.9 -188% 01 Jul 2021 30 Sep 2021
Q2 2021 -1.18 -6.32 -123% 01 Apr 2021 30 Jun 2021
Q1 2021 3.3 -1.09 -24.8% 01 Jan 2021 31 Mar 2021
Q4 2020 6.13 +10.3 01 Oct 2020 31 Dec 2020
Q3 2020 7.4 +25.9 01 Jul 2020 30 Sep 2020
Q2 2020 5.14 +36.9 01 Apr 2020 30 Jun 2020
Q1 2020 4.39 +51.6 01 Jan 2020 31 Mar 2020
Q4 2019 -4.17 +52.9 +92.7% 01 Oct 2019 31 Dec 2019
Q3 2019 -18.5 +34.3 +65% 01 Jul 2019 30 Sep 2019
Q2 2019 -31.8 +20.5 +39.2% 01 Apr 2019 30 Jun 2019
Q1 2019 -47.2 +9.47 +16.7% 01 Jan 2019 31 Mar 2019
Q4 2018 -57.1 -5.34 -10.3% 01 Oct 2018 31 Dec 2018
Q3 2018 -52.7 +4.96 +8.6% 01 Jul 2018 30 Sep 2018
Q2 2018 -52.3 +17.1 +24.7% 01 Apr 2018 30 Jun 2018
Q1 2018 -56.7 +17.6 +23.7% 01 Jan 2018 31 Mar 2018
Q4 2017 -51.7 +22.8 +30.6% 01 Oct 2017 31 Dec 2017
Q3 2017 -57.7 +12.2 +17.5% 01 Jul 2017 30 Sep 2017
Q2 2017 -69.5 -0.17 -0.25% 01 Apr 2017 30 Jun 2017
Q1 2017 -74.3 01 Jan 2017 31 Mar 2017
Q4 2016 -74.5 01 Oct 2016 31 Dec 2016
Q3 2016 -69.9 01 Jul 2016 30 Sep 2016
Q2 2016 -69.3 01 Apr 2016 30 Jun 2016

NovoCure Ltd Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -46.8 +4.86 +9.41% 01 Jan 2024 31 Dec 2024
2023 -51.6 -30.7 -146% 01 Jan 2023 31 Dec 2023
2022 -21 -6.33 -43.2% 01 Jan 2022 31 Dec 2022
2021 -14.7 -20.8 -339% 01 Jan 2021 31 Dec 2021
2020 6.13 +10.3 01 Jan 2020 31 Dec 2020
2019 -4.17 +52.9 +92.7% 01 Jan 2019 31 Dec 2019
2018 -57.1 -5.34 -10.3% 01 Jan 2018 31 Dec 2018
2017 -51.7 +22.8 +30.6% 01 Jan 2017 31 Dec 2017
2016 -74.5 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.